SPDR S&P Biotech ETF (XBI) Holdings $86.90 +1.74 (+2.05%) As of 03:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 XBI HoldingsRankCompanyCurrent PriceWeightShares Held1MRNAModerna$25.47+0.0%2.72%4,198,6342ALNYAlnylam Pharmaceuticals$431.77-0.7%2.60%390,2453EXELExelixis$37.31-0.3%2.60%2,812,2104NBIXNeurocrine Biosciences$127.63+2.9%2.57%938,2955UTHRUnited Therapeutics$299.33-0.4%2.55%421,3736HALOHalozyme Therapeutics$63.16+0.4%2.53%2,163,6207INSMInsmed$118.84+5.3%2.53%1,189,0968REGNRegeneron Pharmaceuticals$558.49+2.3%2.53%224,6759VRTXVertex Pharmaceuticals$382.88+2.2%2.46%257,62810AMGNAmgen$283.90-0.4%2.44%399,268 Get the Latest News and Ratings for XBI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. 11BMRNBioMarin Pharmaceutical$56.77-0.1%2.42%2,038,29212ABBVAbbVie$197.79-0.4%2.39%608,37113GILDGilead Sciences$119.74-0.6%2.39%1,065,92914INCYIncyte$81.48+2.9%2.38%1,692,23815BBIOBridgeBio Pharma$48.09-0.3%2.30%2,384,95816BIIBBiogen$129.39+1.1%2.27%875,63217EXASExact Sciences$41.58+1.6%2.19%2,093,15418MDGLMadrigal Pharmaceuticals$354.81+1.5%2.06%297,50019BPMCBlueprint Medicines$129.462.03%756,46920NTRANatera$161.07+2.6%2.01%698,60421CRSPCRISPR Therapeutics$56.38+1.8%1.87%1,385,76922TGTXTG Therapeutics$26.49+0.4%1.79%2,281,01923ROIVRoivant Sciences$11.60+3.8%1.70%7,160,79324CYTKCytokinetics$34.53+3.9%1.59%2,054,05625IONSIonis Pharmaceuticals$40.67-0.4%1.52%1,754,383 Geographic ExposureUnited States94.5%Bermuda1.7%Switzerland1.6%Ireland1.1%Virgin Islands, British0.5%Netherlands0.2%Canada0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care98.4%Consumer Discretionary1.0%Biotechnology0.3%Energy0.1%Industry ExposureBiotechnology93.0%Health Care Equipment & Supplies3.5%Health Care Providers & Services2.2%Distributors0.9%Renewable Energy0.1%Diversified Consumer Services0.1%SubIndustry ExposureBiotechnology93.1%Life Sciences Tools & Services3.2%Health Care Services2.2%Pharmaceuticals0.7%Health Care Equipment0.2%Renewable Energy Equipment0.1%Health Care Supplies0.1% Related Companies and Tools Related Companies IHI Portfolio Companies IBB Portfolio Companies IXJ Portfolio Companies IYH Portfolio Companies FHLC Portfolio Companies FBT Portfolio Companies RYH Portfolio Companies FXH Portfolio Companies RSPH Portfolio Companies IHF Portfolio Companies This page (NYSEARCA:XBI) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredTop Picks for Trump’s Pro-Crypto America27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access